NYSE:MDC - M.D.C. Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$29.95 -0.44 (-1.45 %)
(As of 06/24/2018 12:55 PM ET)
Previous Close$29.95
Today's Range$29.61 - $30.68
52-Week Range$26.45 - $37.45
Volume831,217 shs
Average Volume471,028 shs
Market Capitalization$1.71 billion
P/E Ratio11.61
Dividend Yield3.95%
Beta1.49
M.D.C. logoM.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Colorado, Utah, Virginia, Florida, Maryland, Pennsylvania, and New Jersey. Its financial services operations consist of originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Operative builders
Sub-IndustryHomebuilding
SectorConstruction
SymbolNYSE:MDC
CUSIP55267610
Phone303-773-1100

Debt

Debt-to-Equity Ratio0.75
Current Ratio9.79
Quick Ratio2.68

Price-To-Earnings

Trailing P/E Ratio11.61
Forward P/E Ratio8.71
P/E Growth0.51

Sales & Book Value

Annual Sales$2.58 billion
Price / Sales0.65
Cash Flow$2.6837 per share
Price / Cash11.16
Book Value$25.09 per share
Price / Book1.19

Profitability

EPS (Most Recent Fiscal Year)$2.58
Net Income$141.83 million
Net Margins6.04%
Return on Equity11.99%
Return on Assets6.28%

Miscellaneous

Employees1,491
Outstanding Shares56,220,000

The Truth About Cryptocurrencies

M.D.C. (NYSE:MDC) Frequently Asked Questions

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Monday, April 30th. Shareholders of record on Wednesday, May 16th will be paid a dividend of $0.30 per share on Wednesday, May 23rd. This represents a $1.20 dividend on an annualized basis and a yield of 4.01%. The ex-dividend date of this dividend is Tuesday, May 15th. View M.D.C.'s Dividend History.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) posted its quarterly earnings data on Thursday, May, 3rd. The construction company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.15. The construction company earned $607.69 million during the quarter, compared to analyst estimates of $584.58 million. M.D.C. had a net margin of 6.04% and a return on equity of 11.99%. M.D.C.'s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.40 earnings per share. View M.D.C.'s Earnings History.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for M.D.C..

What price target have analysts set for MDC?

9 brokers have issued 1-year target prices for M.D.C.'s shares. Their forecasts range from $30.00 to $39.00. On average, they expect M.D.C.'s stock price to reach $33.5714 in the next year. View Analyst Ratings for M.D.C..

Who are some of M.D.C.'s key competitors?

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the folowing people:
  • Mr. Larry A. Mizel, Chairman & CEO (Age 75)
  • Mr. David D. Mandarich, Pres, COO & Director (Age 70)
  • Mr. Robert Nathaniel Martin, Sr. VP, CFO & Principal Accounting Officer (Age 39)
  • Mr. Michael Touff, Sr. VP & Gen. Counsel (Age 73)
  • Mr. Kelly Taga, Chief Information Officer and VP

Has M.D.C. been receiving favorable news coverage?

News articles about MDC stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. M.D.C. earned a news sentiment score of 0.10 on Accern's scale. They also assigned press coverage about the construction company an impact score of 47.79 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.43%), Dimensional Fund Advisors LP (8.44%), LSV Asset Management (2.64%), Allianz Asset Management GmbH (1.76%), Allianz Asset Management GmbH (1.76%) and Northern Trust Corp (1.53%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Michael A Berman, Michael Touff and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

Which institutional investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Principal Financial Group Inc., Principal Financial Group Inc., Federated Investors Inc. PA, Smith Asset Management Group LP, Wells Fargo & Company MN, Atlantic Trust Group LLC and JPMorgan Chase & Co.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

Which institutional investors are buying M.D.C. stock?

MDC stock was purchased by a variety of institutional investors in the last quarter, including LSV Asset Management, BlackRock Inc., Denver Investment Advisors LLC, Goelzer Investment Management Inc., Heartland Advisors Inc., Opus Capital Group LLC, A.R.T. Advisors LLC and Allianz Asset Management GmbH. View Insider Buying and Selling for M.D.C..

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $29.95.

How big of a company is M.D.C.?

M.D.C. has a market capitalization of $1.71 billion and generates $2.58 billion in revenue each year. The construction company earns $141.83 million in net income (profit) each year or $2.58 on an earnings per share basis. M.D.C. employs 1,491 workers across the globe.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]


MarketBeat Community Rating for M.D.C. (MDC)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  200 (Vote Outperform)
Underperform Votes:  323 (Vote Underperform)
Total Votes:  523
MarketBeat's community ratings are surveys of what our community members think about M.D.C. and other stocks. Vote "Outperform" if you believe MDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.